Page last updated: 2024-10-29

amrinone and Liver Dysfunction

amrinone has been researched along with Liver Dysfunction in 4 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"The effects of amrinone, a selective phosphodiesterase III inhibitor, on liver ischaemia reperfusion injury have not yet been clarified."9.09Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1. ( Chang, K; Hanaoka, K; Hayashida, M; Makuuchi, M; Orii, R; Sugawara, Y; Takayama, T; Yamada, Y, 2000)
"The present study was designed to investigate the effect of amrinone, a phosphodiesterase III inhibitor, on hepatic ischemia-reperfusion injury in rats."7.71Effects of amrinone on hepatic ischemia-reperfusion injury in rats. ( Imamura, H; Kobayashi, T; Makuuchi, M; Ohkubo, T; Sugawara, Y, 2002)
"The effects of amrinone, a selective phosphodiesterase III inhibitor, on liver ischaemia reperfusion injury have not yet been clarified."5.09Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1. ( Chang, K; Hanaoka, K; Hayashida, M; Makuuchi, M; Orii, R; Sugawara, Y; Takayama, T; Yamada, Y, 2000)
"The present study was designed to investigate the effect of amrinone, a phosphodiesterase III inhibitor, on hepatic ischemia-reperfusion injury in rats."3.71Effects of amrinone on hepatic ischemia-reperfusion injury in rats. ( Imamura, H; Kobayashi, T; Makuuchi, M; Ohkubo, T; Sugawara, Y, 2002)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kucuk, C1
Akcan, A1
Akyýldýz, H1
Akgun, H1
Muhtaroglu, S1
Sozuer, E1
Ishiki, J1
Orii, R1
Sugawara, Y2
Hayashida, M1
Yamada, Y1
Chang, K1
Takayama, T1
Makuuchi, M2
Hanaoka, K1
Kobayashi, T1
Ohkubo, T1
Imamura, H1

Reviews

1 review available for amrinone and Liver Dysfunction

ArticleYear
[Perioperative management of renal circulation].
    Masui. The Japanese journal of anesthesiology, 1997, Volume: 46 Suppl

    Topics: Amrinone; Anesthesia; Animals; Glycoproteins; Hemodynamics; Humans; Intraoperative Period; Kidney Tr

1997

Trials

1 trial available for amrinone and Liver Dysfunction

ArticleYear
Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1.
    British journal of anaesthesia, 2000, Volume: 85, Issue:3

    Topics: Aged; Alprostadil; Amrinone; Analysis of Variance; Female; Hepatectomy; Humans; Indocyanine Green; L

2000

Other Studies

2 other studies available for amrinone and Liver Dysfunction

ArticleYear
Effects of amrinone in an experimental model of hepatic ischemia-reperfusion injury.
    The Journal of surgical research, 2009, Volume: 151, Issue:1

    Topics: Adenosine Triphosphate; Alanine Transaminase; Amrinone; Animals; Aspartate Aminotransferases; Biopsy

2009
Effects of amrinone on hepatic ischemia-reperfusion injury in rats.
    Journal of hepatology, 2002, Volume: 37, Issue:1

    Topics: Alanine Transaminase; Amrinone; Animals; Aspartate Aminotransferases; Blotting, Western; Cyclic AMP;

2002